BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1Simon J. Hogg, Ricky W. Johnstone|Cell Reports|2017Cited by 297
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J. Hogg, Ricky W. Johnstone, Hannah D. Coughlan et al.|Molecular Cell|2021Cited by 167